USFDA closes inspection of Dr. Reddy's Srikakulam unit with 'Voluntary Action Indicated' classification

RDY•2026-10-29

The USFDA classified Dr. Reddy's Laboratories' Srikakulam unit inspection as “Voluntary Action Indicated” and officially closed the inspection. The pre-approval and good manufacturing practices inspections were disclosed on July 29, 2026.

USFDA closes inspection of Dr. Reddy's Srikakulam unit with 'Voluntary Action Indicated' classification

1. Inspection closed

Related News

DoorDash strikes $17 billion deal for US rival Instacart in grocery delivery push

Ocular Therapeutix joins UBS Global Biopharma Conference fireside chat

EPR Properties: Stifel cuts target price to $67.5 from $70.5

Sources

USFDA closes inspection of Dr. Reddy's Srikakulam unit with 'Voluntary Action Indicated' classification

Stifel cuts ClearPoint Neuro target price to $18 from $22

Ocugen to present gene therapy platform at investor and industry conferences